Search Results 1151-1160 of 11274 for Antifungal Resistance
Clinical Trials · A Study To Compare The Efficacy And Safety Of BMS-986353 (Zolacaptagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard Of Care In ...
Participants who are red blood cell transfusion dependent must also have failed erythropoiesis stimulating agents (primary resistance or relapse after a ...
... fungal, parasitic or protozoal infection; History of malignancy (active or ... A minority of patients with celiac-like enteropathy are resistant to ...
Active bacterial or fungal infection requiring intravenous systemic therapy (except as indicated, discuss alternative scenarios with the Medical Monitor).
... fungal sinusitis (AFRS) with an emphasis on cytokines and BMPs present, and to identify BMPs differentially elevated in patients with AFRS compared to ...
The purpose of this study is to assess the safety and tolerability, identify dose-limiting toxicities (DLT) and determine the maximum tolerated dose (MTD) / ...
... resistant); OR; Prior allergic reaction to carboplatin or cisplatin. Measureable disease, defined as at least one lesion whose longest diameter can be ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Presence of any active infections (excluding fungal or bacterial infections that require only topical antimicrobials) including, but not limited to, those ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.